Division of Cardiology, Department of Medical Sciences, Città Della Salute E Della Scienza Di Torino Hospital, University of Torino, Corso Bramante 88, 10141, Torino, Italy.
University of Milano Statale, Milano, Italy.
Intern Emerg Med. 2021 Apr;16(3):551-558. doi: 10.1007/s11739-021-02639-6. Epub 2021 Feb 28.
Recurrent pericarditis is a true challenge for clinicians, especially when the patient becomes unresponsive or not tolerant to conventional treatments. An accurate diagnosis of recurrent pericarditis, possibly supported by advanced imaging tools, is critical to provide timely and appropriate treatment of symptoms and prevention of further episodes. The incessant research on the inflammatory pathways underlying cardiovascular diseases, led recently to the assessment of anti interleukin-1 agents in the setting of recurrent pericarditis. This review will focus on the diagnostic assessment of recurrent pericarditis, along with the most modern therapeutic advances in this field. Bibliographic databases were searched (MEDLINE/PubMed, BioMed Central, the Cochrane Collaboration Database of Randomized Trials, Scopus, ClinicalTrials.gov, EMBASE, Google Scholar) using the terms "recurrent pericarditis" AND "diagnosis" OR "treatment" OR "IL-1" OR "inflammation".
复发性心包炎对临床医生来说是一个真正的挑战，尤其是当患者对常规治疗无反应或不耐受时。准确诊断复发性心包炎，可能需要先进的影像学工具支持，对于及时和适当治疗症状以及预防进一步发作至关重要。最近，心血管疾病炎症途径的不断研究导致了评估复发性心包炎中抗白细胞介素-1 药物的应用。这篇综述将重点关注复发性心包炎的诊断评估，以及该领域的最新治疗进展。使用术语“复发性心包炎”和“诊断”或“治疗”或“IL-1”或“炎症”，在文献数据库（MEDLINE/PubMed、BioMed Central、Cochrane 协作数据库的随机对照试验、Scopus、ClinicalTrials.gov、EMBASE、Google Scholar）中进行了检索。
